524669 Stock Overview
Manufactures and trades in veterinary vaccines and animal health products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Hester Biosciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,377.75 |
| 52 Week High | ₹3,375.45 |
| 52 Week Low | ₹1,292.90 |
| Beta | 0.70 |
| 11 Month Change | 3.64% |
| 3 Month Change | -3.93% |
| 1 Year Change | 54.58% |
| 33 Year Change | 3.37% |
| 5 Year Change | 50.46% |
| Change since IPO | 56,966.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524669 | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | -3.7% | -0.5% | 0.3% |
| 1Y | 54.6% | 42.7% | 27.3% |
Return vs Industry: 524669 exceeded the Indian Biotechs industry which returned 42.7% over the past year.
Return vs Market: 524669 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 524669 volatility | |
|---|---|
| 524669 Average Weekly Movement | 5.5% |
| Biotechs Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524669 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524669's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 642 | Rajiv Gandhi | www.hester.in |
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis.
Hester Biosciences Limited Fundamentals Summary
| 524669 fundamental statistics | |
|---|---|
| Market cap | ₹20.23b |
| Earnings (TTM) | ₹234.69m |
| Revenue (TTM) | ₹3.16b |
86.2x
P/E Ratio6.4x
P/S RatioIs 524669 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524669 income statement (TTM) | |
|---|---|
| Revenue | ₹3.16b |
| Cost of Revenue | ₹939.87m |
| Gross Profit | ₹2.22b |
| Other Expenses | ₹1.99b |
| Earnings | ₹234.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.59 |
| Gross Margin | 70.30% |
| Net Profit Margin | 7.42% |
| Debt/Equity Ratio | 76.1% |
How did 524669 perform over the long term?
See historical performance and comparison